Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Roboz Surgical Instrument is a private U.S. surgical instrument company focused on supplying precision instruments and related products for the biomedical, life science research, and healthcare markets. Founded in 1953 by Otto Roboz, the company markets a broad catalog of more than 1,000 products including tweezers and forceps, scissors, micro-dissection tools, retractors, scalpels, wound-closure products, vascular access products, bone instruments, and instrument care and handling equipment. Roboz positions itself as a designer and developer of surgical instruments used by research and healthcare professionals worldwide. The business appears to be primarily a commercial supplier of research and surgical tools rather than a therapeutics developer, with no disclosed drug pipeline or clinical-stage assets. Its core value proposition is specialized, high-quality, hand-crafted or precision surgical instrumentation for laboratory and procedural use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Roboz Surgical Instrument.